Drug intelligence / Profile preview

pimonidazole

Development stage
Phase 2
Modality
Small Molecules
Administration
Intravenous
01

Overview

Pimonidazole is a small molecule belonging to the nitroimidazole class, primarily used as a hypoxia marker in research and clinical diagnostics. It is selectively reduced in hypoxic environments—such as those found within solid tumors—where it forms stable adducts with thiol groups in proteins, peptides, and amino acids. This property allows for the identification and quantification of hypoxic cells using immunohistochemical techniques. Pimonidazole has also been investigated for its radiosensitizing properties due to its ability to deplete radioprotective thiol compounds in tumor cells, potentially making them more susceptible to radiation therapy. Its main applications are as a diagnostic tool for assessing tumor hypoxia in cancers such as prostate cancer and head and neck cancer[1][2][5][8].

Brand names
Hypoxyprobe-1Hypoxyprobe1Hypoxyprobe 1
Other names
pimonidazole hydrochloridepimonidazole HCl
02

Targets

GSH (Glutathione)Intracellular thiol-containing proteins

Beyond the preview

Go deeper on pimonidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pimonidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call